As researchers race to identify new therapeutics, streamlined antibody discovery processes have never been more crucial, and the need for speed and efficiency is paramount. The development of ...

Doctors may order a cyclic citrullinated peptide (CCP) antibody test and other exams to confirm or rule out a rheumatoid arthritis (RA) diagnosis. A positive CCP antibody test doesn’t necessarily mean ...

Antibody discovery research paves the way for new therapeutics. The search for the right antibody for a specific therapeutic application necessitates several iterations of antibody production and ...

Monoclonal antibodies (mAbs) bind to a variety of targets with high affinity and specificity, making them ideal therapeutics. However, traditional approaches to antibody screening workflows are labor ...

Existing monoclonal antibody development technologies, such as hybridoma technology, suffer from a loss of diversity due to cell fusion efficiency, and phage display technology creates antibodies ...

The FDA has issued emergency authorizations to 12 antibody tests for the virus. As federal officials gradually begin reopening the country, expanded testing is central to the conversation. Until now, ...

A novel biomarker derived from Epstein-Barr virus (EBV) significantly improved the diagnostic accuracy for nasopharyngeal carcinoma, a large screening study from China showed. Screening with P85-Ab, ...

The development of potent and selective monoclonal antibodies (mAbs) is a significant challenge. More than 25 antibodies have been approved for human therapy and over 240 antibodies are being ...